Study Design: Retrospective review of prospective database Objectives: To define the variability of neurologic examination and recovery after nonpenetrating complete thoracic spinal cord injuries (ASIA A).
INTRODUCTION
Traumatic spinal cord injuries (SCI) are devastating events that typically affect a younger population, resulting in a significant loss of economic and social productivity. Determining the extent of injury and overall prognosis after a spinal cord injury is a complex process and is presently assessed through the neurologic examination. Unfortunately, in thoracic SCI patients the variability and consistency of these neurologic examinations are unknown, particularly due to the dependence on the sensory examination. Patients with injuries from T2-T10 are presently being targeted for pharmacologic and surgical interventions in future potential SCI therapies, because the distance between the last functioning motor units (T1 level) and the site of neurologic injury decreases their potential for losing motor function. The T10 cut off increases the chance of a pure spinal cord lesion, avoiding the conus medullaris and cauda equina. This examination has been successfully utilized in multiple SCI trials [3] [4] [5] ; however, its variability in isolated thoracic SCI is unknown. Unlike the cervical spinal cord injuries where the exact neurological level (NL) can be confirmed by the physical examination through both a motor and sensory level, the thoracic ASIA level (below T1) is defined by only the sensory portion of the examination. This article, therefore, analyzes a large population of complete thoracic SCI patients (ASIA A) to assess the variability of the thoracic ASIA examination.
METHODS
This is a retrospective review of the data obtained from the Sygen pharmaceutical trial for spinal cord injured patients specifically analyzing the placebo control patients who did not receive the study medication (Sygen). 6 The Sygen study was a prospective, double blind, randomized, stratified, multicenter trial of the influence of a GM1 ganglioside on neurologic recovery after SCI. Full details of the trial's design, recruitment and enrollment have been previously published. 6, 7 As part of the study, patients were excluded for the presence of: The neurologic level (NL) of injury defined by the ASIA exam localizes functioning and injured motor neurons and sensory fibers in relation to the spinal cord anatomy.
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The ASIA examination has been validated in terms of its ability to quantify the degree of patient's neurologic injury as well as potential for further neurologic recovery. 19 Waters et al illustrated that the absence of sacral sparing of sensation is the most reliable and clinically useful definition of a complete spinal cord injury and is the premise of the ASIA A (complete) definition. 20 Thoracic ASIA A SCI patients, however, are the most difficult to clinically assess changes since their ASIA level has neither discrete anatomic landmarks nor concurrent motor nerve roots to verify the level.
Although the ASIA examination has been validated in SCI populations, there has been limited evaluation of the complete thoracic ASIA A SCI patients due to their small numbers. can be correlated to the cervical SCI data, which shows that there is the potential for single level of return juxtaposed to the level of injury. [22] [23] [24] Interestingly, the greatest variability in the thoracic ASIA A examination occurred during the first 4 week period after injury. This is most likely attributed to the early influence of surgical intervention (positive or negative), difficulty in precisely localizing the level due to a patient population in significant pain, sedation and being in an ICU setting. (Figure 2 ) However, examinations after the four week period illustrated remarkably similar and consistent results.
This stabilization of the examination might be the result of the ability to obtain consistent neurologic assessments since the patient is in a more controlled environment. However, the multitude of consistent ASIA examinations further suggests that there is a plateau of neurologic recovery, thus inferring no further neurologic improvement after the four week period.
Unfortunately, even the greatest degree of neurologic recovery occurred in only one third of the 
